You are here
OCULAR PROTEOMICS, LLC
UEI: N/A
# of Employees: 3
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development and Commercialization of Predictive Biomarker Panel and In Office Kit for the Management of Diabetic Macular Edema
Amount: $219,009.00Abstract Diabetic Macular Edema DME is a vision threatening stage in Diabetic Retinopathy DR that can result in legal blindness The biochemical mechanisms that drive DME progression are not well ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Development and Commercialization of Ocular Diagnostic Test Based on Vitreous Pro
Amount: $1,206,379.00DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness in people over age 60 in the developed world. Progression of this disease ...
SBIRPhase II2013Department of Health and Human Services National Institutes of Health -
Development and Commercialization of Ocular Diagnostic Tests Based on Vitreous Pr
Amount: $177,367.00DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness in people over age 60 in the developed world. Progression of this disease ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health